Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

April 28, 2024

Study Completion Date

April 28, 2024

Conditions
Smoking Cessation
Interventions
BEHAVIORAL

Phases 1 and 2

Phase 1 participants will help inform the cultural adaptation of the study design and materials. Phase 2 will enroll 10 dyads (20 individuals) of AN/AI people who smoke and a family member. Dyad participants will help beta-test the feasibility and acceptability of the financial incentives intervention.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Alaska Native Tribal Health Consortium

OTHER

lead

Mayo Clinic

OTHER